NCT04294927
Who may be able to join
Who might be able to join this trial:
- You are a woman who has been confirmed to carry a specific harmful gene mutation in one of these genes: BRCA1, BRCA2, RAD51C, RAD51D, or BRIP1, tested at one of the participating medical centres
- Your age falls within the range linked to your specific gene mutation: BRCA1 carriers aged 25–40, BRCA2 carriers aged 25–45, or RAD51C/RAD51D/BRIP1 carriers aged 25–50
- You have finished having children and do not plan to have any more
- You still have at least one fallopian tube (the tubes that connect the ovaries to the uterus)
- You may be able to join even if you have had a previous cancer diagnosis, as long as it was not ovarian, fallopian tube, or peritoneal cancer
- You are willing and able to give written consent to take part in the trial
Who may not be able to join:
- You have already gone through menopause, either naturally or as a result of medical treatment
- You are planning to have your ovaries removed within two years of joining the trial
- You are not legally able to make your own decisions about medical care
- You have already had both fallopian tubes removed
- You have a personal history of ovarian cancer, fallopian tube cancer, or peritoneal cancer
- You are currently being diagnosed with or treated for any active cancer
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Trial details
Where this trial is recruiting
15 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
High grade serous (ovarian) cancer incidence
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.